March 3, 2020Open Access

Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018

Key Points

Key points are not available for this paper at this time.

Abstract

This study provides an estimate of research and development costs for new therapeutic agents based on publicly available data. Differences from previous studies may reflect the spectrum of products analyzed, the restricted availability of data in the public domain, and differences in underlying assumptions in the cost calculations.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Cite This Study

Wouters et al. (Tue,) studied this question.

synapsesocial.com/papers/69d6ff215413bc3de5ab334c https://doi.org/https://doi.org/10.1001/jama.2020.1166

Discussion

Journals

JAMA

Institutions

KU Leuven

London School of Hygiene & Tropical Medicine

London School of Economics and Political Science

References and Citations

Add This Paper to Your Research Feed

Any time a new paper drops it will be there.